Neurovascular devices market seen reaching $7.49B by 2031

Mordor Intelligence says the global neurovascular devices market is projected to rise from $5.17 billion in 2026 to $7.49 billion by 2031 as stroke, aneurysm and other neurovascular cases climb. North America remains the largest market, while Asia-Pacific is expected to grow the fastest.

Why it matters: - The neurovascular devices market is expanding as more patients need treatment for stroke, cerebral aneurysms and other neurovascular disorders. - Faster diagnosis, more specialized stroke centers and broader use of minimally invasive procedures are pushing demand in hospitals and specialty care settings. - The market’s growth matters because healthcare systems are trying to improve outcomes while cutting procedure time.

What happened: - Mordor Intelligence estimates the global neurovascular devices market at $5.17 billion in 2026. - The market is projected to reach $7.49 billion by 2031. - The forecast implies a 7.67% compound annual growth rate from 2026 to 2031. - North America is the largest regional market.

The details: - The market is being driven by rising cases of ischemic stroke, cerebral aneurysms and related neurovascular conditions. - Healthcare providers are prioritizing timely diagnosis and intervention to improve patient outcomes. - Clinical preference for minimally invasive neurointerventional techniques is supporting adoption. - These procedures are generally linked to shorter recovery periods and lower procedural complexity. - Expansion of comprehensive stroke centers is improving access to advanced interventions. - Healthcare systems are investing in specialized infrastructure, imaging capabilities and care coordination programs. - The report’s product categories include aneurysm coiling and embolization devices, cerebral balloon angioplasty and stenting systems, neurothrombectomy devices, support devices and other devices such as liquid embolics and occlusion balloons. - The report’s disease categories include ischemic stroke, cerebral aneurysm, arteriovenous malformations and fistulas, and intracerebral hemorrhage. - The main end users are hospitals, ambulatory surgical centers and specialty neurology and stroke centers. - The market covers North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. - The report’s regional breakdown includes the U.S., Canada and Mexico in North America; Germany, the U.K., France, Italy, Spain and the rest of Europe; China, Japan, India, Australia, South Korea and the rest of Asia-Pacific; GCC, South Africa and the rest of the Middle East and Africa; and Brazil, Argentina and the rest of South America.

Between the lines: - The market outlook points to a shift toward less invasive care models that can move patients through treatment faster. - North America’s lead reflects stronger stroke-treatment networks and more established adoption of neurovascular procedures. - Asia-Pacific’s growth outlook suggests unmet demand remains high as healthcare infrastructure and stroke awareness improve. - The competitive landscape is shaped by device performance, physician familiarity, procedural efficiency, regulatory compliance and provider relationships. - The report says the market is competitive, with global manufacturers investing in product development, clinical evidence and geographic expansion. - Recent industry activity included Stereotaxis reporting broader adoption of its FDA-cleared robotic endovascular technologies, including its MAGiC catheter platform, across multiple clinical sites in May 2026. - Route 92 Medical also said in May 2026 that it was advancing clinical evaluation of stroke-treatment technologies aimed at faster clot removal.

What's next: - North America is expected to remain the largest market. - Asia-Pacific is expected to be the fastest-growing region. - Ongoing investment in minimally invasive neurointerventional tools and stroke-care infrastructure should continue to support demand through 2031. - The report is available in Japanese, French, German, Spanish and Portuguese. - More information is available in the full report.